Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: PVLA) Delayed: 154.32 +2.89 (1.91%)
Previous Close $151.43    52 Week High
Open $154.78    52 Week Low
Day High $156.79    P/E N/A 
Day Low $151.55    EPS
Volume 153,871